Biofrontera Inc.

Biofrontera Inc. is a U.S.-headquartered biopharmaceutical company dedicated to treating dermatological conditions with photodynamic therapy (PDT). A subsidiary of Germany's Biofrontera AG, it controls clinical innovation through commercialization for the US market, holding full ownership of product patents and NDA/IND applications. Its lead products treat actinic keratosis, and its German subsidiary Biofrontera Discovery GmbH handles clinical development, regulatory affairs, quality assurance, and manufacturing.